Filing Details
- Accession Number:
- 0001179110-12-007466
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-01 18:31:47
- Reporting Period:
- 2012-04-27
- Filing Date:
- 2012-05-01
- Accepted Time:
- 2012-05-01 18:31:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1158223 | Affymax Inc | AFFY | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1477384 | A John Orwin | C/O Affymax, Inc. 4001 Miranda Ave. Palo Alto CA 94304 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-04-27 | 30,000 | $13.35 | 108,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The shares were sold at prices ranging from $13.19 to $13.47. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.